PD-1 Inhibitors
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416) (NCT06631326) | First Hospital of China Medical University | 2021-01-01 |
| Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer (NCT06195254) | Peking University Third Hospital | 2020-12-01 |
| Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. (NCT04490421) | Fuzhou General Hospital | 2020-08-01 |
| PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial (NCT05520814) | Sichuan Cancer Hospital and Research Institute | 2018-08-01 |
Track PD-1 Inhibitors automatically
Every clearance here is in the API, with alerts when new ones post.